2nd Quarter - Report

SPARK THERAPEUTICS, INC. for SPARK THERAPEUTICS, INC.

Firm
Client
Income
—
Expenses
$170,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 2666/S. 4204 - MVP Act, all provisions. Issues related to the CMMI demonstration on Gene and Cell Therapy.

LobbyistCovered position, as disclosed
JEREMY ALLEN —
KATHLEEN M. MCAULIFFE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 4204 (118th), H.R. 2666 (118th)

Health Issues HCR

Issues related to gene therapy and rare diseases.

LobbyistCovered position, as disclosed
JEREMY ALLEN —
KATHLEEN M. MCAULIFFE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

88 FR 85593 Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights, all provisions.

LobbyistCovered position, as disclosed
JEREMY ALLEN —
KATHLEEN M. MCAULIFFE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.